Glycome BioPharma is developing a next-generation technology for safe delivery of injectable biologic drugs.

In all respects, biologics has transformed therapeutic areas, improved patient outcomes, and managed previously untreatable conditions. Yet, biologics are almost exclusively limited to injection administration and formulation in drug delivery devices.

This ready-to-use packaging format facilitates self-medication, improves patient adherence to therapy and reduces hospitalisation costs.

“Glycome BioPharma’s mission is advancing safe injectable drug delivery to enable healthier lives.”